The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy
Open accessAbstract
There is very limited human renal sodium gradient-dependent glucose transporter protein (SGLT2) mRNA and protein expression data reported in the literature. The first aim of this study was to determine SGLT2 mRNA and protein levels in human and animal models of diabetic nephropathy. We have found that the expression of SGLT2 mRNA and protein is increased in renal biopsies from human subjects with diabetic nephropathy. This is in contrast to db-db mice that had no changes in renal SGLT2 protein expression. Furthermore, the effect of SGLT2 inhibition on renal lipid content and inflammation is not known. The second aim of this study was to determine the potential mechanisms of beneficial effects of SGLT2 inhibition in the progression of diabetic renal disease. We treated db/db mice with a selective SGLT2 inhibitor JNJ 39933673. We found that SGLT2 inhibition caused marked decreases in systolic blood pressure, kidney weight/body weight ratio, urinary albumin, and urinary thiobarbituric acid-reacting substances. SGLT2 inhibition prevented renal lipid accumulation via inhibition of carbohydrate-responsive element-binding protein-β, pyruvate kinase L, SCD-1, and DGAT1, key transcriptional factors and enzymes that mediate fatty acid and triglyceride synthesis. SGLT2 inhibition also prevented inflammation via inhibition of CD68 macrophage accumulation and expression of p65, TLR4, MCP-1, and osteopontin. These effects were associated with reduced mesangial expansion, accumulation of the extracellular matrix proteins fibronectin and type IV collagen, and loss of podocyte markers WT1 and synaptopodin, as determined by immunofluorescence microscopy. In summary, our study showed that SGLT2 inhibition modulates renal lipid metabolism and inflammation and prevents the development of nephropathy in db/db mice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boyle, J. P., Thompson, T. J., Gregg, E. W., Barker, L. E., & Williamson, D. F. (2010) · Population Health Metrics · doi:10.1186/1478-7954-8-29 · Cited by 1,309
Oxidative Stress as a Major Culprit in Kidney Disease in Diabetes
Forbes, J. M., Coughlan, M. T., & Cooper, M. E. (2008) · Diabetes · doi:10.2337/db08-0057 · Cited by 1,203
Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients
Ferrannini, E., Muscelli, E., Frascerra, S., Baldi, S., Mari, A., Heise, T., Broedl, U. C., & Woerle, H.-J. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72227 · Cited by 1,134
Temporal trends in the prevalence of diabetic kidney disease in the United States
de Boer, I. H. (2011) · JAMA · doi:10.1001/jama.2011.861 · Cited by 1,036
Rahmoune, H., Thompson, P. W., Ward, J. M., Smith, C. D., Hong, G., & Brown, J. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3427 · Cited by 777
Gorboulev, V., Schürmann, A., Vallon, V., Kipp, H., Jaschke, A., Klessen, D., Friedrich, A., Scherneck, S., Rieg, T., Cunard, R., et al. (2012) · Diabetes · doi:10.2337/db11-1029 · Cited by 687
Self-citationAltered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy
Herman-Edelstein, M., Scherzer, P., Tobar, A., Levi, M., & Gafter, U. (2014) · Journal of Lipid Research · doi:10.1194/jlr.p040501 · Cited by 645
Self-citationVallon, V., & Thomson, S. C. (2017) · Diabetologia · doi:10.1007/s00125-016-4157-3 · Cited by 635
Gerich, J. E. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02894.x · Cited by 633
Barnett, A. H., Mithal, A., Manassie, J., Jones, R., Rattunde, H., Woerle, H. J., & Broedl, U. C. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70208-0 · Cited by 574
SGLT2 Mediates Glucose Reabsorption in the Early Proximal Tubule
Vallon, V., Platt, K. A., Cunard, R., Schroth, J., Whaley, J., Thomson, S. C., Koepsell, H., & Rieg, T. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010030246 · Cited by 563
Self-citationMetabolic Syndrome and Kidney Disease: A Systematic Review and Meta-analysis
Thomas, G., Sehgal, A. R., Kashyap, S. R., Srinivas, T. R., Kirwan, J. P., & Navaneethan, S. D. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02180311 · Cited by 553
Vallon, V., Gerasimova, M., Rose, M. A., Masuda, T., Satriano, J., Mayoux, E., Koepsell, H., Thomson, S. C., & Rieg, T. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00520.2013 · Cited by 483
Self-citationProbing SGLT2 as a therapeutic target for diabetes: basic physiology and consequences
Gallo, L. A., Wright, E. M., & Vallon, V. (2015) · Diabetes and Vascular Disease Research · doi:10.1177/1479164114561992 · Cited by 395
The proximal tubule in the pathophysiology of the diabetic kidney
Vallon, V. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00809.2010 · Cited by 395
Jiang, T., Wang, Z., Proctor, G., Moskowitz, S., Liebman, S. E., Rogers, T., Lucia, M. S., Li, J., & Levi, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500801200 · Cited by 387
Self-citationVallon, V., & Thomson, S. C. (2012) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020911-153333 · Cited by 376
Glucose handling by the kidney
Mather, A., & Pollock, C. (2011) · Kidney International · doi:10.1038/ki.2010.509 · Cited by 375
Weinberg, J. M. (2006) · Kidney International · doi:10.1038/sj.ki.5001834 · Cited by 371
Vallon, V., Rose, M., Gerasimova, M., Satriano, J., Platt, K. A., Koepsell, H., Cunard, R., Sharma, K., Thomson, S. C., & Rieg, T. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00409.2012 · Cited by 370
Self-citationRenal lipid metabolism and lipotoxicity
Bobulescu, I. A. (2010) · Current Opinion in Nephrology and Hypertension · doi:10.1097/mnh.0b013e32833aa4ac · Cited by 364
The Mechanisms and Therapeutic Potential of SGLT2 Inhibitors in Diabetes Mellitus
Vallon, V. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-051013-110046 · Cited by 348
An update on the lipid nephrotoxicity hypothesis
Ruan, X. Z., Varghese, Z., & Moorhead, J. F. (2009) · Nature Reviews Nephrology · doi:10.1038/nrneph.2009.184 · Cited by 344
Terami, N., Ogawa, D., Tachibana, H., Hatanaka, T., Wada, J., Nakatsuka, A., Eguchi, J., Horiguchi, C. S., Nishii, N., Yamada, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100777 · Cited by 341
Sun, L., Halaihel, N., Zhang, W., Rogers, T., & Levi, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110650200 · Cited by 333
Self-citationQian, Y., Feldman, E., Pennathur, S., Kretzler, M., & Brosius, F. C. (2008) · Diabetes · doi:10.2337/db08-0061 · Cited by 325
Thomson, S. C., Rieg, T., Miracle, C., Mansoury, H., Whaley, J., Vallon, V., & Singh, P. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00357.2011 · Cited by 315
Proctor, G., Jiang, T., Iwahashi, M., Wang, Z., Li, J., & Levi, M. (2006) · Diabetes · doi:10.2337/db05-0603 · Cited by 303
Self-citationWang, Z., Jiang, T., Li, J., Proctor, G., McManaman, J. L., Lucia, S., Chua, S., & Levi, M. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2328 · Cited by 303
Self-citationVrhovac, I., Balen Eror, D., Klessen, D., Burger, C., Breljak, D., Kraus, O., Radović, N., Jadrijević, S., Aleksic, I., Walles, T., et al. (2015) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-014-1619-7 · Cited by 290
Self-citationPanchapakesan, U., Pegg, K., Gross, S., Komala, M. G., Mudaliar, H., Forbes, J., Pollock, C., & Mather, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054442 · Cited by 277
The Western-style diet: a major risk factor for impaired kidney function and chronic kidney disease
Odermatt, A. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00068.2011 · Cited by 257
Farnesoid X Receptor Modulates Renal Lipid Metabolism, Fibrosis, and Diabetic Nephropathy
Jiang, T., Wang, X. X., Scherzer, P., Wilson, P., Tallman, J., Takahashi, H., Li, J., Iwahashi, M., Sutherland, E., Arend, L., et al. (2007) · Diabetes · doi:10.2337/db06-1642 · Cited by 236
Self-citationSodium–Glucose Cotransporter Inhibitors: Effects on Renal and Intestinal Glucose Transport
Mudaliar, S., Polidori, D., Zambrowicz, B., & Henry, R. R. (2015) · Diabetes Care · doi:10.2337/dc15-0642 · Cited by 225
β-cell failure as a complication of diabetes
Chang-Chen, K. J., Mullur, R., & Bernal-Mizrachi, E. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9101-5 · Cited by 225
G Protein-Coupled Bile Acid Receptor TGR5 Activation Inhibits Kidney Disease in Obesity and Diabetes
Wang, X. X., Edelstein, M. H., Gafter, U., Qiu, L., Luo, Y., Dobrinskikh, E., Lucia, S., Adorini, L., D’Agati, V. D., Levi, J., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014121271 · Cited by 213
Self-citationRisk for ESRD in Type 1 Diabetes Remains High Despite Renoprotection
Rosolowsky, E. T., Skupien, J., Smiles, A. M., Niewczas, M., Roshan, B., Stanton, R., Eckfeldt, J. H., Warram, J. H., & Krolewski, A. S. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010040354 · Cited by 191
Gembardt, F., Bartaun, C., Jarzebska, N., Mayoux, E., Todorov, V. T., Hohenstein, B., & Hugo, C. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00145.2014 · Cited by 189
Wang, X. X., Jiang, T., Shen, Y., Caldas, Y., Miyazaki-Anzai, S., Santamaria, H., Urbanek, C., Solis, N., Scherzer, P., Lewis, L., et al. (2010) · Diabetes · doi:10.2337/db10-0019 · Cited by 186
Self-citationEFFECT OF DIABETES AND INSULIN ON THE MAXIMUM CAPACITY OF THE RENAL TUBULES TO REABSORB GLUCOSE 1
Farber, S. J., Berger, E. Y., & Earle, D. P. (1951) · Journal of Clinical Investigation · doi:10.1172/jci102424 · Cited by 185
Adenosine signalling in diabetes mellitus—pathophysiology and therapeutic considerations
Antonioli, L., Blandizzi, C., Csóka, B., Pacher, P., & Haskó, G. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.10 · Cited by 183
Wang, X. X., Jiang, T., Shen, Y., Adorini, L., Pruzanski, M., Gonzalez, F. J., Scherzer, P., Lewis, L., Miyazaki-Anzai, S., & Levi, M. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00404.2009 · Cited by 178
Self-citationDe Nicola, L., Gabbai, F. B., Liberti, M. E., Sagliocca, A., Conte, G., & Minutolo, R. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.02.010 · Cited by 167
Guebre-Egziabher, F., Alix, P. M., Koppe, L., Pelletier, C. C., Kalbacher, E., Fouque, D., & Soulage, C. O. (2013) · Biochimie · doi:10.1016/j.biochi.2013.07.017 · Cited by 164
Škrtić, M., & Cherney, D. Z. I. (2014) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000084 · Cited by 156
Scope and mechanisms of obesity-related renal disease
Hunley, T. E., Ma, L., & Kon, V. (2010) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3283374c09 · Cited by 147
Gallo, L. A., Ward, M. S., Fotheringham, A. K., Zhuang, A., Borg, D. J., Flemming, N., Harvie, B. M., Kinneally, T. L., Yeh, S.-M., McCarthy, D. A., et al. (2016) · Scientific Reports · doi:10.1038/srep26428 · Cited by 146
Self-citationThe Renin-Angiotensin System and Diabetic Nephropathy
Gurley, S. B., & Coffman, T. M. (2007) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2007.01.009 · Cited by 144
Structural-functional correlations of diabetic nephropathy
Mauer, S. M. (1994) · Kidney International · doi:10.1038/ki.1994.80 · Cited by 142
Effects of a New SGLT2 Inhibitor, Luseogliflozin, on Diabetic Nephropathy in T2DN Rats
Kojima, N., Williams, J. M., Takahashi, T., Miyata, N., & Roman, R. J. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.203869 · Cited by 142
Adenosine A2Areceptor activation attenuates inflammation and injury in diabetic nephropathy
Awad, A. S., Huang, L., Ye, H., Duong, E. T. A., Bolton, W. K., Linden, J. M., & Okusa, M. D. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00310.2005 · Cited by 137
Ishibashi, Y., Matsui, T., & Yamagishi, S. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1555791 · Cited by 119
Sodium glucose cotransporter 2 inhibition in the diabetic kidney: an update
Novikov, A., & Vallon, V. (2015) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000187 · Cited by 108
Maeda, S., Matsui, T., Takeuchi, M., & Yamagishi, S. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2407 · Cited by 90
Wang, X. X., Jiang, T., Shen, Y., Santamaria, H., Solis, N., ARBEENY, C. M., & Levi, M. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00338.2010 · Cited by 90
Self-citationLack of A1 Adenosine Receptors Augments Diabetic Hyperfiltration and Glomerular Injury
Faulhaber‐Walter, R., Chen, L., Oppermann, M., Kim, S. M., Huang, Y. G., Hiramatsu, N., Mizel, D. E., Kajiyama, H., Zerfas, P. M., Briggs, J. P., et al. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007060721 · Cited by 90
Self-citationRegulation of Transforming Growth Factor β in Diabetic Nephropathy: Implications for Treatment
Zhu, Y., Usui, H. K., & Sharma, K. (2007) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2007.01.008 · Cited by 89
Bank, N., & Aynedjian, H. S. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114700 · Cited by 89
Tubular reabsorption and diabetes‐induced glomerular hyperfiltration
Persson, P., Hansell, P., & Palm, F. (2010) · Acta Physiologica · doi:10.1111/j.1748-1716.2010.02147.x · Cited by 86
Ferrannini, E., Veltkamp, S. A., Smulders, R. A., & Kadokura, T. (2013) · Diabetes Care · doi:10.2337/dc12-1503 · Cited by 81
Podocytes, Signaling Pathways, and Vascular Factors in Diabetic Kidney Disease
Brosius, F. C., & Coward, R. J. (2014) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2014.03.011 · Cited by 74
Renal effects of dapagliflozin in patients with type 2 diabetes
Thomas, M. C. (2014) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018814544153 · Cited by 71
Stanton, R. C. (2013) · Circulation · doi:10.1161/circulationaha.113.007071 · Cited by 62
Sodium glucose cotransporter 2 and the diabetic kidney
Komala, M. G., Panchapakesan, U., Pollock, C. A., & Mather, A. (2012) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32835a17ae · Cited by 60
Tak, E., Ridyard, D. G., Kim, J., Zimmerman, M., Werner, T., Wang, X. X., Shabeka, U., Seo, S.-W., Christians, U., Klawitter, J., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012101014 · Cited by 55
Self-citationGiral, H., Cranston, D., Lanzanò, L. L., Caldas, Y. A., Sutherland, E. M., Rachelson, J., Dobrinskikh, E., Weinman, E. J., Doctor, R. B., Gratton, E., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.392415 · Cited by 45
Self-citationAdenosine mediates transforming growth factor‐beta 1 release in kidney glomeruli of diabetic rats
Roa, H., Gajardo, C., Troncoso, E., Fuentealba, V., Escudero, C., Yáñez, A. J., Sobrevía, L., Pastor‐Anglada, M., Quezada, C., & Martín, R. S. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.09.003 · Cited by 44
Adenosine A2B receptor-mediated VEGF induction promotes diabetic glomerulopathy
Cárdenas, A., Toledo, C., Oyarzun, C. E., Sepúlveda, A., Quezada, C., Guillén‐Gómez, E., Encarnación, M. M. D., Pastor‐Anglada, M., & Martín, R. S. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.143 · Cited by 43
Schnermann, J. B. (2015) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021014-071829 · Cited by 35
SGLT-2 inhibitors: Their pleiotropic properties
Vallianou, N. G., Geladari, E. V., & Kazazis, C. E. (2016) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2016.12.003 · Cited by 29
Mende, C. W. (2016) · Current Medical Research and Opinion · doi:10.1080/03007995.2016.1271779 · Cited by 25
Cited by
CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease
Anders, H.-J., Huber, T. B., Isermann, B., & Schiffer, M. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0001-y · Cited by 796
Effects of SGLT2 Inhibitors on Kidney and Cardiovascular Function
Vallon, V., & Verma, S. (2021) · Annual Review of Physiology · doi:10.1146/annurev-physiol-031620-095920 · Cited by 516
The tubular hypothesis of nephron filtration and diabetic kidney disease
Vallon, V., & Thomson, S. C. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0256-y · Cited by 465
Renoprotective effects of sodium-glucose cotransporter-2 inhibitors
Heerspink, H. J. L., Kosiborod, M., Inzucchi, S. E., & Cherney, D. Z. I. (2018) · Kidney International · doi:10.1016/j.kint.2017.12.027 · Cited by 393
Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities
Opazo-Ríos, L., Mas, S., Marín-Royo, G., Mezzano, S., Gómez-Guerrero, C., Moreno, J. A., & Egido, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072632 · Cited by 363
Metadata
- Authors
- Wang, X. X., Levi, J., Luo, Y., Myakala, K., Herman-Edelstein, M., Qiu, L., Wang, D., Peng, Y., Grenz, A., Lucia, S., Dobrinskikh, E., D'Agati, V. D., Koepsell, H., Kopp, J. B., Rosenberg, A. Z., & Levi, M.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2017-03
- Volume
- 292
- Issue
- 13
- Pages
- 5335-5348
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2588592529
- Cited by
- 306
- References
- 71
- FWCI
- 22.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.